Your Duties:
You will quickly take on responsibility and bring your experience to the following duties, helping to make a positive impact on the lives of countless patients:
You will assume personal responsibility for preparing patient tumor samples forhistology (cutting on the microtome and dying the sections).
Your duties will also include extracting DNA/RNA from tissue and blood andpreparing samples for NGS sequencing (libraries, hybridization).
You will be responsible for performing high-throughput DNA sequencing (NGS).
You will also automated operate liquid-handling platforms for sample processing.
You will personally oversee the implementation of projects both at national andinternational level.
You will independently plan and perform quality controls and validations and draftthe accompanying standard regulations (SOPs).
You will personally oversee and drive forward the ongoing maintenance of qualitystandards in the laboratory and the improvement of laboratory processes.
Finally, you will ensure that our laboratory equipment is in full working order.
Your Profile:
You will need to meet the following requirements for the role:
You have completed a master’s degree in a scientific discipline.
You have experience in molecular genetics, particularly in the field of NGS technology.
You are familiar with working in an accredited diagnostic laboratory, in boththeory and practice.
Ideally, you have some initial experience working in accordance with SOPs in aregulated environment.
You are comfortable using common IT tools, particularly MS Excel and PowerPoint.
You are a team player and are happy to share your knowledge as an expert contactperson for technical questions and to give instructions on how to perform analyses.
You are reliable and have outstanding communication and organizational skills.
Finally, you have a good specialist knowledge of English, both written and verbal.
We are a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer.